- Home
- YMM vs RGEN Comparison
YMM vs RGEN Comparison
Compare YMM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMM
- RGEN
- Stock Information
- Founded
- YMM 2011
- RGEN 1981
- Country
- YMM China
- RGEN United States
- Employees
- YMM N/A
- RGEN N/A
- Industry
- YMM Computer Software: Prepackaged Software
- RGEN Medical/Dental Instruments
- Sector
- YMM Technology
- RGEN Health Care
- Exchange
- YMM Nasdaq
- RGEN Nasdaq
- Market Cap
- YMM 7.5B
- RGEN 8.2B
- IPO Year
- YMM 2021
- RGEN N/A
- Fundamental
- Price
- YMM $7.16
- RGEN $141.78
- Analyst Decision
- YMM Hold
- RGEN Buy
- Analyst Count
- YMM 1
- RGEN 10
- Target Price
- YMM $7.00
- RGEN $188.38
- AVG Volume (30 Days)
- YMM 6.9M
- RGEN 934.6K
- Earning Date
- YMM 08-21-2024
- RGEN 10-29-2024
- Dividend Yield
- YMM 2.00%
- RGEN N/A
- EPS Growth
- YMM 58.99
- RGEN N/A
- EPS
- YMM 0.33
- RGEN N/A
- Revenue
- YMM $1,335,489,684.00
- RGEN $602,354,000.00
- Revenue This Year
- YMM N/A
- RGEN $0.08
- Revenue Next Year
- YMM $22.19
- RGEN $12.97
- P/E Ratio
- YMM $21.84
- RGEN N/A
- Revenue Growth
- YMM 29.48
- RGEN N/A
- 52 Week Low
- YMM $5.70
- RGEN $110.45
- 52 Week High
- YMM $9.68
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- YMM 45.10
- RGEN 43.50
- Support Level
- YMM $7.00
- RGEN $138.80
- Resistance Level
- YMM $7.38
- RGEN $150.72
- Average True Range (ATR)
- YMM 0.23
- RGEN 4.98
- MACD
- YMM 0.02
- RGEN -0.92
- Stochastic Oscillator
- YMM 39.31
- RGEN 24.50
About YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.